SyzOnc

www.syzonc.com
2929 Arch St, Fl 4
Philadelphia, PA 19104

Company Info

Year Established
2023

Contacts

Karin Eisinger, Ph.D.
Co-Founder & CEO

Company Description

SyzOnc is developing tumor microenvironment modulators for cancer patients using a tech-enabled, systems-level approach.

bioinnovatise accelerates scientific discovery by providing fast, reliable, and high-quality CDMO services for plasmid DNA and viral vector-based research.